Drug profile · INN
sacubitril + valsartan
ENTRESTO
sacubitril + valsartan (ENTRESTO) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — sacubitril + valsartan
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
sacubitril + valsartan (ENTRESTO) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is sacubitril + valsartan?
sacubitril + valsartan (ENTRESTO) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals.
What is the brand name for sacubitril + valsartan?
ENTRESTO is a marketed brand name for sacubitril + valsartan. Check FDA Drugs@FDA for the current US label holder and prescribing information.